Recruiting

RePaReREGENETEN Bioinductive Implant System for Rotator Cuff Repair: Real World Post-Market Evaluation

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to observe and evaluate the real-world effectiveness of the REGENETEN Bioinductive Implant System in patients who have undergone rotator cuff repair, using measures such as the EuroQol 5 Dimension 5 Level Score, Oxford Shoulder Score, Pain Visual Analog Scale Score, Quick DASH Score, and Single Assessment Numeric Evaluation Score.

What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Shoulder Injuries+2

+ Rotator Cuff Injuries

+ Rupture

Over 18 Years
+5 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: October 2020
See protocol details

Summary

Principal SponsorSmith & Nephew, Inc.
Study ContactSarah TurnerMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: October 1, 2020

Actual date on which the first participant was enrolled.

This study focuses on individuals undergoing rotator cuff repair using the REGENETEN◊ Bioinductive Implant System. The main goal is to gather real-world data from up to 400 patients across 50 centers in the UK, Europe, and Australia. The study aims to understand the clinical and health economic outcomes following this specific type of rotator cuff repair. This research is important as it can provide valuable insights into the effectiveness and cost-efficiency of the REGENETEN◊ Bioinductive Implant System in real-world settings, potentially improving care for those with rotator cuff injuries. Patients participating in this study will receive treatment and evaluation according to standard medical care. The study will collect outcome data for up to 2 years post-surgery. The outcomes measured include the EuroQol 5 Dimension 5 Level (EQ-5D-5L) score, Oxford Shoulder Score (OSS), Pain Visual Analog Scale (VAS) score, Quick DASH (Disabilities of Arm, Shoulder and Hand) score, and Single Assessment Numeric Evaluation (SANE) score. These measures assess various aspects of a patient's health and quality of life, such as mobility, self-care, usual activities, pain, and overall shoulder condition. Higher scores in these measures generally indicate better outcomes.

Official TitleEvaluation Of Clinical and Health Economic Outcomes Following Rotator Cuff Repair Using the REGENETEN◊ Bioinductive Implant: A Prospective, Multi-Center Global Registry
NCT06857084
Principal SponsorSmith & Nephew, Inc.
Study ContactSarah TurnerMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

400 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Shoulder InjuriesRotator Cuff InjuriesRuptureTendon InjuriesWounds and Injuries

Criteria

2 inclusion criteria required to participate
Subject requires Arthroscopic rotator cuff repair (ARCR)

Patients aged over 18 years old at the time of consent and providing baseline data before undergoing rotator cuff repair surgery (either partial or full thickness tears) will be eligible for this prospective registry

3 exclusion criteria prevent from participating
Subject who, in the opinion of the Investigator, has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the registry including mental illness, intellectual disability, and drug or alcohol abuse

Subjects who do not meet the indication or are contraindicated according to specific Smith+Nephew REGENETEN System's Instructions for Use (IFUs)

Subject that meets the definition of a Vulnerable Subject per ISO14155:2020 Section 3.44

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 19 locations

Recruiting

Burnley General Teaching Hospital

Burnley, United KingdomOpen Burnley General Teaching Hospital in Google Maps
Recruiting

Manchester University NHS Foundation Trust

Manchester, United Kingdom
Recruiting

Grantham and District Hospital

Grantham, United Kingdom
Recruiting

University College London Hospitals

London, United Kingdom
Recruiting
19 Study Centers